Kailera Therapeutics, Inc. (KLRA) stock
KLRANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 4, 2026
$11.79−0.41 (-3.36%)
Close on Nov 18, 2026Market cap $1.53BP/E –Yield –
Kailera Therapeutics cash
Cash and short-term investments held at the end of each period.
Kailera Therapeutics's cash was $1.04B at Sep 30, 2026. For fiscal 2025 it was $546.06M.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $546.06M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.04B | +959.7% |
| Q2 FY2026 | Jun 30, 2026 | $1.17B | +1055.9% |
| Q1 FY2026 | Mar 31, 2026 | $581.90M | +471.7% |
| Q4 FY2025 | Dec 31, 2025 | $546.06M | – |
| Q3 FY2025 | Sep 30, 2025 | $97.91M | – |
| Q2 FY2025 | Jun 30, 2025 | $101.37M | – |
| Q1 FY2025 | Mar 31, 2025 | $101.78M | – |
See a number that looks wrong?